Evidence map›Paper›PMID 36968256›Full record

ArticleSocial network analysis and mining2023

Diachronic profile of startup companies through social media.

Ana Rita Peixoto, Ana de Almeida, Nuno António, Fernando Batista, Ricardo Ribeiro

Full text read
In one paragraph

Article in Social network analysis and mining, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ana Rita PeixotoInstituto Universitário de Lisboa (ISCTE-IUL), ISTAR, Lisbon, Portugal.
Ana de AlmeidaInstituto Universitário de Lisboa (ISCTE-IUL), ISTAR, Lisbon, Portugal.
Nuno AntónioNOVA Information Management School (NOVA IMS), Universidade Nova de Lisboa, Campus de Campolide, Lisbon, Portugal.
Fernando BatistaINESC-ID Lisboa, Lisbon, Portugal.
Ricardo RibeiroINESC-ID Lisboa, Lisbon, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Social media platforms have become powerful tools for startups, helping them find customers and raise funding. In this study, we applied a social media intelligence-based methodology to analyze startups' content and to understand how their communication strategies may differ during their scaling process. To understand if a startup's social media content reflects its current business maturation position, we first defined an adequate life cycle model for startups based on funding rounds and product maturity. Using Twitter as the source of information and selecting a sample of known Portuguese IT startups at different phases of their life cycle, we analyzed their Twitter data. After preprocessing the data, using latent Dirichlet allocation, topic modeling techniques enabled the categorization of the data according to the topics arising in the published contents of the startups, making it possible to discover that contents can be grouped into five specific topics: "Fintech and ML," "IT," "Business Operations," "Product/Service R&D," and "Bank and Funding." By comparing those profiles against the startup's life cycle, we were able to understand how contents change over time. This provided a diachronic profile for each company, showing that while certain topics remain prevalent in the startup's scaling, others depend on a particular phase of the startup's cycle. Our analysis revealed that startups' social media content differs along their life cycle, highlighting the importance of understanding how startups use social media at different stages of their development.

Indexed as

Life cycle modelSocial mediaStartupsTopic modelingTwitter data

Identifiers

PMID36968256
PMCPMC10024031

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read8
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.